The Biosolutions Technology Center offers state-of-the-art pilot facilities and expert support for the scaling and validation of biorefining and fermentation processes. It enables companies to bridge the gap between laboratory development and industrial production, facilitating the creation of sustainable bio-based products such as alternative proteins and food ingredients.
The Biosolutions Technology Center (BTC) provides essential pilot-scale infrastructure and expert support for companies looking to bridge the gap between laboratory research and full-scale industrial production. By offering integrated services for biorefining, fermentation, and downstream processing, the center enables businesses to validate sustainable biosolutions, such as alternative proteins and novel food ingredients, under real-world conditions. This facility serves as a critical partner for startups and established enterprises aiming to de-risk investments and accelerate the commercialization of bio-based products and circular processes.
The center offers a comprehensive suite of food-grade, pilot-scale equipment and expertise, including:
The center provides facilities and expertise to support technology development ranging from early-stage pilot validation (TRL 4-5) through to pre-commercial scale-up (TRL 6-7). By facilitating the production of material quantities required for market testing and consumer acceptance, the BTC directly enables the advancement of biosolutions toward full commercial deployment.
Danish Technological Institute is an independent, non‑profit research and technology organization of national scope. Headquartered in Taastrup with facilities across Denmark, it provides applied R&D, prototyping, and accredited testing and certification tightly aligned to industry needs. Co‑located pilot and demonstration facilities, industrial testbeds, and training programs enable partners to validate, scale, and adopt new technologies under real‑world conditions. Research and innovation activities are supported by competitive Danish and European funding, including national innovation programs and EU framework initiatives. A dedicated commercialization function supports IP strategy, licensing, and collaborative agreements.